SARAH DOUGHERTY: Open Payments
NPI 1881036259 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 98 payments from 16 companies in 2025. Trend: 2023 $1,665 · 2024 $3,324 · 2025 $2,311
Food & beverage: $2,055Education: $256
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $481 |
| ABBVIE INC. | 22 | $354 |
| GENZYME CORPORATION | 10 | $311 |
| Regeneron Healthcare Solutions, Inc. | 8 | $239 |
| LEO Pharma Inc. | 6 | $158 |
| Galderma Laboratories, L.P. | 11 | $139 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Arcutis Biotherapeutics, Inc. | 6 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
| Amgen Inc. | 4 | $69 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, ADBRY, Zoryve, AKLIEF, Winlevi, OTEZLA.
Industry payments across KY — which companies pay providers there.
